Comparative pharmacokinetic analysis based on nonlinear mixed effect model.
- Author:
Lu-jin LI
1
;
Xian-xing LI
;
Ling XU
;
Ying-hua LÜ
;
Jun-chao CHEN
;
Qing-shan ZHENG
Author Information
1. The Center for Drug Clinical Research, Shanghai University of Chinese Medicine, Shanghai, 201203, China.
- Publication Type:Journal Article
- MeSH:
Area Under Curve;
Confidence Intervals;
Humans;
Nonlinear Dynamics;
Pharmacokinetics;
Sampling Studies
- From:
Acta Pharmaceutica Sinica
2011;46(4):447-453
- CountryChina
- Language:Chinese
-
Abstract:
Comparative pharmacokinetic (PK) analysis is often carried out throughout the entire period of drug development, the common approach for the assessment of pharmacokinetics between different treatments requires that the individual PK parameters, which employs estimation of 90% confidence intervals for the ratio of average parameters, such as AUC and Cmax, these 90% confidence intervals then need to be compared with the pre-specified equivalent interval, and last we determine whether the two treatments are equivalent. Unfortunately in many clinical circumstances, some or even all of the individuals can only be sparsely sampled, making the individual evaluation difficult by the conventional non-compartmental analysis. In such cases, nonlinear mixed effect model (NONMEM) could be applied to analyze the sparse data. In this article, we simulated a sparsely sampling design trial based on the dense sampling data from a truly comparative PK study. The sparse data were analyzed with NONMEM method, and the original dense data were analyzed with non-compartment analysis. Although the trial design and analysis methods are different, the 90% confidence intervals for the ratio of PK parameters based on 1000 Bootstrap are very similar, indicated that the analysis based on NONMEM is a reliable method to treat with the sparse data in the comparative pharmacokinetic study.
